Temporal association of constipation and diarrhoea with a subsequent diagnosis of colorectal cancer: a propensity score–matched case–control study using real-world primary care data - Top-Institutions - MDSpire

Temporal association of constipation and diarrhoea with a subsequent diagnosis of colorectal cancer: a propensity score–matched case–control study using real-world primary care data

  • By

  • Ernst W Kolbe

  • Sarah Krieg

  • Christoph Roderburg

  • Sven H Loosen

  • Andreas Krieg

  • Karel Kostev

  • July 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • Oncology

  • #2

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, California

    Key Differentiators

    • Gastroenterology
    • Oncology

  • #3

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Gastroenterology
    • Oncology

  • #4

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, Tennessee

    Key Differentiators

    • Gastroenterology
    • Oncology

  • #5

    Shiga University of Medical Science
    Shiga University of Medical Science

    Shiga, Japan

    Key Differentiators

    • Gastroenterology

Original Source(s)

Temporal association of constipation and diarrhoea with a subsequent diagnosis of colorectal cancer: a propensity score–matched case–control study using real-world primary care data

  • by Ernst W Kolbe, Sarah Krieg, Christoph Roderburg, Sven H Loosen, Andreas Krieg, Karel Kostev

  • July 6, 2026

Related Content

Next-generation CAR-T engineering for colorectal cancer: integrating targets, tumor microenvironment barriers, and emerging strategies

NAFLD-associated immune remodeling in colorectal cancer liver metastasis: mechanisms and implications for immunotherapy

Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastases